Literature DB >> 25515427

Speech and swallow rehabilitation following partial glossectomy: a systematic review.

Katrina M Blyth1, Patricia McCabe, Cate Madill, Kirrie J Ballard.   

Abstract

PURPOSE: Tongue cancer is known to negatively affect both speech and swallowing function; however this is the first review to report speech-language pathology (SLP) intervention for both functions following partial glossectomy.
METHOD: Using a PRISMA approach, systematic screening of nine databases was undertaken. Original studies reporting SLP rehabilitation for speech and/or swallowing dysfunction with participants following partial glossectomy as primary cancer treatment were included. RESULT: These studies are discussed in terms of SLP assessment and intervention trends as well as quality according to current research method standards (levels of evidence, Pedro-P, SCED) in order to determine suitability for guiding current clinical practice.
CONCLUSION: Publications were few (n = 7) and mostly of non-experimental design. This review highlights the gap in evidence and questions the rationale of current SLP rehabilitation following partial glossectomy.

Entities:  

Keywords:  Tongue cancer; rehabilitation; speech; speech-language pathology; swallowing

Mesh:

Year:  2014        PMID: 25515427     DOI: 10.3109/17549507.2014.979880

Source DB:  PubMed          Journal:  Int J Speech Lang Pathol        ISSN: 1754-9507            Impact factor:   2.484


  2 in total

1.  Data mining of an acoustic biomarker in tongue cancers and its clinical validation.

Authors:  Yudong Xiao; Tao Wang; Wei Deng; Le Yang; Bin Zeng; Xiaomei Lao; Sien Zhang; Xiangqi Liu; Daiqiao Ouyang; Guiqing Liao; Yujie Liang
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

2.  Quality of life in tongue cancer treated patients before and after speech therapy: a randomized clinical trial.

Authors:  Jordana Balbinot; Caroline Santana Real; Cecília Corte de Melo; Sílvia Dornelles; Sady Selaimen da Costa
Journal:  Braz J Otorhinolaryngol       Date:  2020-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.